A nurse is planning care for a group of clients. Which of the following client’s medications should be monitored by the nurse for hearing loss related to a medication interaction?

A. Digoxin and levothyroxine. These medications do not typically interact to cause hearing loss. Digoxin is used for heart conditions, and levothyroxine is a thyroid hormone replacement. Their interaction does not pose a risk for ototoxicity. B. Furosemide and amikacin. This combination is known to cause ototoxicity. Furosemide is a loop diuretic, and amikacin is an aminoglycoside antibiotic. Both drugs have ototoxic potential, and their combined use increases the risk of hearing loss. C. Losartan and atorvastatin. These medications do not typically interact to cause hearing loss. Losartan is an antihypertensive, and atorvastatin is a cholesterol-lowering agent. Their interaction does not pose a risk for ototoxicity. D. Propranolol and raloxifene. These medications do not typically interact to cause hearing loss. Propranolol is a beta-blocker, and raloxifene is used for osteoporosis. Their interaction does not pose a risk for ototoxicity.